Institutional Ownership
Vaxcyte Inc
CUSIP 92243G108COMPCVXQ1 2026
13D / 13G Filings
46
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
327
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
46 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | T. Rowe Price Investment Management, Inc. | 13G/A | 8.6% | 11.30M | SEC |
| 2 | Nov 14, 2025 | T. Rowe Price Investment Management, Inc. | 13G | 6.4% | 8.32M | SEC |
| 3 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 10.1% | 13.10M | SEC |
| 4 | Sep 8, 2025 | Fmr LLC | 13G/A | 10.1% | 13.13M | SEC |
| 5 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 11.4% | 14.69M | SEC |
| 6 | Aug 6, 2025 | Fmr LLC | 13G/A | 9.4% | 12.10M | SEC |
| 7 | May 15, 2025 | Ra Capital Management, L.P. | 13G/A | 9.9% | 12.96M | SEC |
| 8 | May 7, 2025 | Janus Henderson Group PLC | 13G/A | 11.3% | 14.54M | SEC |
| 9 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 7.6% | 9.83M | SEC |
| 10 | Feb 14, 2025 | Janus Henderson Group PLC | 13G/A | 8.5% | 10.58M | SEC |
36 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Vaxcyte Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 16.58M | $960.23M |
| 2 | Fmr LLC | 16.49M | $958.40M |
| 3 | Ra Capital Management, L.P. | 11.47M | $666.79M |
| 4 | Blackrock, Inc. | 10.97M | $637.57M |
| 5 | Wellington Management Group LLP | 5.61M | $326.26M |
| 6 | Paradigm Biocapital Advisors LP | 4.79M | $278.52M |
| 7 | State Street Corp | 4.44M | $258.04M |
| 8 | Deep Track Capital, LP | 4.30M | $249.87M |
| 9 | Westfield Capital Management Co LP | 3.65M | $211.88M |
| 10 | Geode Capital Management, LLC | 3.20M | $186.06M |